美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Orexigen Therapeutics

0.2229

0.0000

成交量：- -

成交额：- -

市值：420.99万

市盈率：-0.02

高：0.2229

开：0.2229

低：0.2229

收：0.2229

52周最高：3.81

52周最低：0.1708

股本：1,888.70万

流通股本：967.74万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-9.7006

净资产收益率：--

总资产收益率：--

市净率：-0.07

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Orexigen Therapeutics

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.orexigen.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Orexigen Therapeutics, Inc.于2002年9月在特拉华成立。Orexigen治疗股份有限公司是一家生物制药公司，专注于发展治疗肥胖的候选医药产品。公司的主导产品有针对肥胖者的已完成三期临床试验的纳曲酮和已完成二期临床试验的empati。纳曲酮是两个行之有效的药物的组合，包括安非他酮，纳曲酮。安非他酮是一种广泛应用的抗抑郁药和戒烟药物；纳曲酮用于酒精和阿片成瘾治疗。Empatic的组合是安非他酮和唑尼沙胺，唑尼沙胺立即释放制剂在美国被批准用于部分癫痫发作的辅助治疗。每个候选产品在商业化之前都将获得监管机构的批准。公司在努力的向监管机构证明这些组合的疗效和安全性，以获得批准。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/OREX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"OREX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OREX\",,,,,undefined,":{"symbol":"OREX","market":"US","secType":"STK","nameCN":"Orexigen Therapeutics","latestPrice":0.2229,"timestamp":1522785600000,"preClose":0.2229,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":9677447,"shares":18887033,"eps":-9.700626,"marketStatus":"退市","change":0,"latestTime":"02-24 13:47:30 EST","open":0.2229,"high":0.2229,"low":0.2229,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.700626,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1177560000000,"exchange":"NASDAQ","adjPreClose":0.2229,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OREX\",,,,,undefined,":{"symbol":"OREX","floatShares":9677447,"roa":"--","roe":"--","lyrEps":0,"shares":18887033,"dividePrice":0,"high":0.2229,"amplitude":0,"preClose":0.2229,"low":0.2229,"week52Low":0.1708,"pbRate":"-0.07","week52High":3.805,"institutionHeld":0.9018,"latestPrice":0.2229,"eps":-9.700626,"divideRate":0,"volume":0,"delay":0,"ttmEps":-9.700626,"open":0.2229},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OREX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-11-13","symbol":"OREX","fiscalQuarterEnding":"2017/09","expectedEps":-2.13,"name":null,"time":"盘后","type":"earning","dateTimestamp":1510549200000,"reportTimeType":"post","actualEps":-1.35},{"market":"US","date":"2017-08-08","symbol":"OREX","fiscalQuarterEnding":"2017/06","expectedEps":-2.4,"name":null,"time":"盘后","type":"earning","dateTimestamp":1502164800000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2017-05-09","symbol":"OREX","fiscalQuarterEnding":"2017/03","expectedEps":-2.6,"name":null,"time":"盘后","type":"earning","dateTimestamp":1494302400000,"reportTimeType":"post","actualEps":-4.67},{"market":"US","date":"2017-03-28","symbol":"OREX","fiscalQuarterEnding":"2016/12","expectedEps":-0.54,"name":null,"time":"盘前","type":"earning","dateTimestamp":1490673600000,"reportTimeType":"pre","actualEps":-2.67},{"market":"US","date":"2016-11-03","symbol":"OREX","fiscalQuarterEnding":"2016/09","expectedEps":-2.13,"name":null,"time":"盘后","type":"earning","dateTimestamp":1478145600000,"reportTimeType":"post","actualEps":-1.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OREX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OREX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.orexigen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Orexigen Therapeutics, Inc.于2002年9月在特拉华成立。Orexigen治疗股份有限公司是一家生物制药公司，专注于发展治疗肥胖的候选医药产品。公司的主导产品有针对肥胖者的已完成三期临床试验的纳曲酮和已完成二期临床试验的empati。纳曲酮是两个行之有效的药物的组合，包括安非他酮，纳曲酮。安非他酮是一种广泛应用的抗抑郁药和戒烟药物；纳曲酮用于酒精和阿片成瘾治疗。Empatic的组合是安非他酮和唑尼沙胺，唑尼沙胺立即释放制剂在美国被批准用于部分癫痫发作的辅助治疗。每个候选产品在商业化之前都将获得监管机构的批准。公司在努力的向监管机构证明这些组合的疗效和安全性，以获得批准。","exchange":"NASDAQ","name":"Orexigen Therapeutics","nameEN":"Orexigen Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OREX\",market:\"US\",,,undefined,":null}}